211 related articles for article (PubMed ID: 23707302)
1. ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration.
Carlessi L; Fusar Poli E; De Filippis L; Delia D
DNA Repair (Amst); 2013 Aug; 12(8):605-11. PubMed ID: 23707302
[TBL] [Abstract][Full Text] [Related]
2. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
Lavin MF
DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
[TBL] [Abstract][Full Text] [Related]
3. Brain and induced pluripotent stem cell-derived neural stem cells as an in vitro model of neurodegeneration in ataxia-telangiectasia.
Carlessi L; Fusar Poli E; Delia D
Exp Biol Med (Maywood); 2013 Mar; 238(3):301-7. PubMed ID: 23598976
[TBL] [Abstract][Full Text] [Related]
4. A nervous predisposition to unrepaired DNA double strand breaks.
Reynolds JJ; Stewart GS
DNA Repair (Amst); 2013 Aug; 12(8):588-99. PubMed ID: 23684796
[TBL] [Abstract][Full Text] [Related]
5. The role of ATM and DNA damage in neurons: upstream and downstream connections.
Herrup K; Li J; Chen J
DNA Repair (Amst); 2013 Aug; 12(8):600-4. PubMed ID: 23680599
[TBL] [Abstract][Full Text] [Related]
6. Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status.
Lee Y; Chong MJ; McKinnon PJ
J Neurosci; 2001 Sep; 21(17):6687-93. PubMed ID: 11517258
[TBL] [Abstract][Full Text] [Related]
7. A patient-derived olfactory stem cell disease model for ataxia-telangiectasia.
Stewart R; Kozlov S; Matigian N; Wali G; Gatei M; Sutharsan R; Bellette B; Wraith-Kijas A; Cochrane J; Coulthard M; Perry C; Sinclair K; Mackay-Sim A; Lavin MF
Hum Mol Genet; 2013 Jun; 22(12):2495-509. PubMed ID: 23474819
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of Cytoplasmic DNA Due to ATM Deficiency Activates the Microglial Viral Response System with Neurotoxic Consequences.
Song X; Ma F; Herrup K
J Neurosci; 2019 Aug; 39(32):6378-6394. PubMed ID: 31189575
[TBL] [Abstract][Full Text] [Related]
9. Ataxia telangiectasia syndrome: moonlighting ATM.
Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
[TBL] [Abstract][Full Text] [Related]
10. Cellular functions of the protein kinase ATM and their relevance to human disease.
Lee JH; Paull TT
Nat Rev Mol Cell Biol; 2021 Dec; 22(12):796-814. PubMed ID: 34429537
[TBL] [Abstract][Full Text] [Related]
11. Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells.
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):296-305. PubMed ID: 27596957
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia.
Sharma NK; Lebedeva M; Thomas T; Kovalenko OA; Stumpf JD; Shadel GS; Santos JH
DNA Repair (Amst); 2014 Jan; 13():22-31. PubMed ID: 24342190
[TBL] [Abstract][Full Text] [Related]
13. Analysis of ionizing radiation induced DNA damage response in human adult stem cells and differentiated neurons.
Meador JA; Balajee AS
Mutat Res Genet Toxicol Environ Mutagen; 2022 Jun; 878():503486. PubMed ID: 35649680
[TBL] [Abstract][Full Text] [Related]
14. Correction of ATM mutations in iPS cells from two ataxia-telangiectasia patients restores DNA damage and oxidative stress responses.
Ovchinnikov DA; Withey SL; Leeson HC; Lei UW; Sundarrajan A; Junday K; Pewarchuk M; Yeo AJ; Kijas AW; Lavin MF; Wolvetang EJ
Hum Mol Genet; 2020 Apr; 29(6):990-1001. PubMed ID: 32037450
[TBL] [Abstract][Full Text] [Related]
15. Role of DDX1 in the oxidative response of ataxia telangiectasia patient-derived fibroblasts.
Garg M; Li L; Godbout R
Redox Biol; 2024 Feb; 69():102988. PubMed ID: 38096740
[TBL] [Abstract][Full Text] [Related]
16. Mutations in String/CDC25 inhibit cell cycle re-entry and neurodegeneration in a Drosophila model of Ataxia telangiectasia.
Rimkus SA; Katzenberger RJ; Trinh AT; Dodson GE; Tibbetts RS; Wassarman DA
Genes Dev; 2008 May; 22(9):1205-20. PubMed ID: 18408079
[TBL] [Abstract][Full Text] [Related]
17. Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency.
Carlessi L; Fusar Poli E; Bechi G; Mantegazza M; Pascucci B; Narciso L; Dogliotti E; Sala C; Verpelli C; Lecis D; Delia D
Cell Death Dis; 2014 Jul; 5(7):e1342. PubMed ID: 25032865
[TBL] [Abstract][Full Text] [Related]
18. A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype.
Quek H; Luff J; Cheung K; Kozlov S; Gatei M; Lee CS; Bellingham MC; Noakes PG; Lim YC; Barnett NL; Dingwall S; Wolvetang E; Mashimo T; Roberts TL; Lavin MF
Hum Mol Genet; 2017 Jan; 26(1):109-123. PubMed ID: 28007901
[TBL] [Abstract][Full Text] [Related]
19. Telomere and ATM Dynamics in CD4 T-Cell Depletion in Active and Virus-Suppressed HIV Infections.
Khanal S; Tang Q; Cao D; Zhao J; Nguyen LN; Oyedeji OS; Dang X; Nguyen LNT; Schank M; Thakuri BKC; Ogbu C; Morrison ZD; Wu XY; Zhang Z; He Q; El Gazzar M; Li Z; Ning S; Wang L; Moorman JP; Yao ZQ
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907975
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.
Campbell A; Krupp B; Bushman J; Noble M; Pröschel C; Mayer-Pröschel M
Hum Mol Genet; 2015 Nov; 24(22):6331-49. PubMed ID: 26310626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
